Statutory Petition Requirement Correctable Back in April I discussed the Patent Trial & Appeal Board’s (PTAB) evolving position that an updated RPI... Read More »

CASE OF THE WEEK Gilead Sciences, Inc. v. Merck & Co., Inc., Appeal Nos. 2016-2302, -2615 (Fed. Cir. 2018) In an appeal from a bench trial finding patents ... Read More »

On April 25th, a Fed. Cir. panel of Judges Taranto, Clevenger and Chen affirmed the unenforceability of two Merck patents covering a drug presently marketed as... Read More »